Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Myelitis
ADR ID BADD_A02923
ADR Hierarchy
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.03      Central nervous system and spinal infections
11.01.03.007      Myelitis
17      Nervous system disorders
17.06      Central nervous system infections and inflammations
17.06.02      Myelitis (incl infective)
17.06.02.001      Myelitis
Description A disorder characterized by inflammation involving the spinal cord. Symptoms include weakness, paresthesia, sensory loss, marked discomfort and incontinence. [CTCAE] Inflammation of the spinal cord. Relatively common etiologies include infections; AUTOIMMUNE DISEASES; SPINAL CORD; and ischemia (see also SPINAL CORD VASCULAR DISEASES). Clinical features generally include weakness, sensory loss, localized pain, incontinence, and other signs of autonomic dysfunction. [MeSH]
MedDRA Code 10028524
MeSH ID D009187
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Myelitis | Myelitis NOS | Myeloradiculitis | Meningomyelitis | Myelitides | Spinal Cord Inflammation | Inflammations, Spinal Cord | Spinal Cord Inflammations | Inflammation, Spinal Cord | Myelopathy, Inflammatory | Inflammatory Myelopathies | Inflammatory Myelopathy | Myelopathies, Inflammatory | Subacute Necrotising Myelitis | Myelitis, Subacute Necrotising | Necrotising Myelitis, Subacute | Infectious Myelitis | Myelitis, Infectious
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00417Cetirizine--
BADD_D00418Cetirizine hydrochloride--
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
BADD_D01063Hepatitis b vaccine--
BADD_D01180Iohexol--
BADD_D01181Iopamidol--
BADD_D01397Mesalamine--
BADD_D01679Paroxetine--
BADD_D01680Paroxetine hydrochloride--
BADD_D01681Paroxetine hydrochloride hemihydrate--
BADD_D01682Paroxetine impurity a--
BADD_D01683Paroxetine mesylate--
BADD_D01735Pergolide--
BADD_D01736Pergolide mesylate--
BADD_D01835Pregabalin--
BADD_D01916Rasagiline mesylate--
The 1th Page    1    Total 1 Pages